. Author manuscript; available in PMC: 2015 Mar 10.

Published in final edited form as: Liver Transpl. 2015 Feb 10;21(3):308–313. doi: 10.1002/lt.24063

TABLE 1.

Baseline Characteristics of the Cohort at Listing and at LT

	At Listing (n = 69,213)	At LT (n = 23,446)
Age (years)^*	54.1 (9.6)	53.0 (9.7)
Males [n (%)]	45,666 (66)	15,687 (67)
Hepatitis C [n (%)]	25,927 (37)	8568 (37)
Cholestatic cirrhosis [n (%)]	5038 (7)	2126 (9)
Noncholestatic cirrhosis [n (%)]	25,270 (37)	10,188 (43)
Caucasian race [n (%)]	49,167 (71)	17,100 (73)
MELD score^*	16.7 (8.1)	25.3 (8.4)
Serum sodium (mmol/L)^*	136 (4.8)	135 (5.4)
Serum creatinine (mg/dL)^*	1.3 (1.2)	1.8 (1.5)
Serum bilirubin (mg/dL)^*	4.9 (7.6)	10.8 (11.9)
International normalized ratio^*	1.6 (0.7)	2.1 (1.2)
Renal replacement therapy [n (%)]	2658 (3.8)	3593 (15)
Albumin (g/dL)^*	3.1 (0.7)	2.9 (0.7)

The data are presented as means (with standard deviations in parentheses).